Xeris Biopharma Holdings, Inc.XERSNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank89
3Y CAGR+27.3%
5Y CAGR+31.6%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+27.3%/yr
vs +53.4%/yr prior
5Y CAGR
+31.6%/yr
Recent deceleration
Acceleration
-26.1pp
Decelerating
Percentile
P89
Within normal range
vs 5Y Ago
4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $29.08M | -12.3% |
| 2024 | $33.17M | +24.7% |
| 2023 | $26.61M | +88.7% |
| 2022 | $14.10M | +96.4% |
| 2021 | $7.18M | -2.4% |
| 2020 | $7.36M | +2.8% |
| 2019 | $7.16M | +181.5% |
| 2018 | $2.54M | +127150.0% |
| 2017 | $2000.00 | 0.0% |
| 2016 | $2000.00 | - |